Differential action of pamidronate on trabecular and cortical bone in women with involutional osteoporosis

Osteoporosis International

Volumn 1, Issue 3, 1991, Pages 129-133

  Fromm, G A ^a   Vega, E ^b   Plantalech, L ^a   Galich, A M ^a   Mautalen, C A ^b  

^a HOSPITAL ITALIANO DE BUENOS AIRES   (Argentina)

^b HOSPITAL DE CLÍNICAS JOSÉ DE SAN MARTÍN   (Argentina)

Author keywords

Bone mineral density; Femoral neck; Lumbar spine; Pamidronate; Trochanter

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE; PAMIDRONIC ACID;

ADULT; AGED; ARTICLE; BONE DENSITY; COHORT ANALYSIS; COMPARATIVE STUDY; DRUG EFFECT; FEMALE; FEMUR; HUMAN; LUMBAR VERTEBRA; POSTMENOPAUSE OSTEOPOROSIS;

AGED; BONE DENSITY; COHORT STUDIES; COMPARATIVE STUDY; DIPHOSPHONATES; FEMALE; FEMUR; HUMAN; LUMBAR VERTEBRAE; MIDDLE AGE; OSTEOPOROSIS, POSTMENOPAUSAL;

EID: 0026167084     PISSN: 0937941X     EISSN: 14332965     Source Type: Journal    
DOI: 10.1007/BF01625440     Document Type: Article

References (28)

1. Treatment of Paget's disease with (3-amino-l-hydroxypropylidene)-1,1-bisphosphonate (APD)
2. Oral versus intravenous AHP.Bp (APD) in the treatment of hypercalcemia of malignancy
3. Bisphosphonate therapy with APD in involutional osteoporosis with vertebral crush fractures
4. Maintained improvement in calcium balance and bone mineral content in patients with osteoporosis treated with the bisphosphonate APD
5. Modification of specific assay for hydroxyproline in urine
6. Bone mineral content in the normal population of Buenos Aires
7. Bone mineral density of the lumbar spine and proximal femur in normal females of Buenos Aires
8. Spine and femur density using dual photon absorptiometry in US white women
9. Bone density of the radius, spine and proximal femur in osteoporosis
10. Prevention of steroid-induced osteoporosis with (3-amino-1-hydroxy-propylidene)-l-l-bisphosphonate (APD)
11. Prevention of glucocorticoid induced osteoporosis
12. Changes in bone density of the proximal femur and spine with aging. Differences between the postmenopausal and senile osteoporosis syndromes
13. Treatment of osteoporosis by manipulation of coherent bone cell population
14. Coherence therapy does not prevent axial bone loss in osteoporotic women: a preliminary comparative study
15. Effects of cyclical therapy for osteoporosis using an oral regimen of inorganic phosphate and sodium etidronate: a clinical and bone histomorphometric study
16. Effect of intermittent cyclical etidronate therapy on bone mass and fracture rate in women with postmenopausal osteoporosis
17. Intermittent cyclical etidronate treatment of postmenopausal osteoporosis
18. The treatment of Paget's bone disease with sodium etidronate
19. Effects of one-year treatment with estrogens on bone mass, intestinal calcium absorption and 25-hydroxyvitamin D-l-hydroxylase reserve in postmenopausal osteoporosis
20. The minimum effective dose of estrogens for prevention of postmenopausal bone loss
21. Bone turnover on postmenopausal osteoporosis. Effect of calcitonin treatment
22. Efficacy of a nasal spray of salmon calcitonin in halting bone loss at the lumbar spine in patients after oophorectomy
23. Monitoring of fluoride therapy in osteoporosis by dual photon absorptiometry
24. The response of bone mineral density during the treatment of osteoporosis with sodium fluoride
25. Editorial. New treatments for osteoporosis. Lancet 1990; 335: 1065–6.
26. Bone diminution of osteoporotic females at different skeletal sites
27. Changes in bone mass and fracture type in patients with hip fractures
28. The second hip fracture. An epidemiologic study